Coronary and Peripheral Stents Market Outlook (2022-2033)

The coronary and peripheral stents market size is expected to reach US$ 20,230.87 million by 2033 from US$ 9,327.81 million in 2024. The market is estimated to record a CAGR of 9.2% from 2025 to 2033.

Executive Summary and Global Market Analysis:

The market for coronary and peripheral stents is heavily influenced by the increasing prevalence of cardiovascular disease, particularly as the population ages, lifestyles become increasingly sedentary, and risk factors such as diabetes and obesity continue to trend upwards. Additionally, numerous technological advances, including ultrathin designs, bioresorbable scaffolds, and dual-therapy stents, will continue to increase procedural success rates and patient long-term outcomes. Increased preference of minimally invasive intervention, along with intravascular imaging to help optimize stent placement, are also contributing to the growth.

Moreover, peripheral stents are gaining traction due to the rising incidence of peripheral artery disease, particularly in diabetic and elderly patients. Favorable reimbursement policies, ongoing clinical trials, and the introduction of dedicated stents for complex anatomies, such as bifurcations and below-the-knee lesions, are creating new growth opportunities. However, pricing pressures and regulatory challenges may limit the market expansion.

Coronary and Peripheral Stents Market Strategic Insights

Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contribute to the derivation of the coronary and peripheral stents market analysis are product type, material type, application, and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds and others. The drug-eluting stents segment dominated the market in 2024.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer and hybrid. The metal segment dominated the market in 2024.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment held a larger share of the market in 2024.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024.

Coronary and Peripheral Stents Market Drivers and Opportunities:

Growing Adoption of Drug-Eluting Stents (DES)

The growing preference for drug-eluting stents is a significant driver in the coronary and peripheral stents market. These stents possess a coating of drugs that is delivered slowly over time to prevent frequent narrowing of the artery. This has improved long-term clinical outcomes than bare-metal stents. Advancements in stent platforms, polymer coatings, and antiproliferative drugs have further enhanced safety and efficacy, making DES the preferred choice for a wide range of patient profiles. Guideline endorsements, positive long-term clinical data, and broader availability in emerging healthcare markets have further accelerated their use. The increased use of DES illustrates a shift toward technologies that reduces adverse events, increase patient satisfaction minimizes the need for repeat procedures, making DES a central element in modern interventional cardiology.

Rising Prevalence of Coronary Artery Disease

The increasing prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD) is a key factor fueling growth in the stents market. These conditions occur when coronary arteries become clogged with plaque, reducing blood flow and increasing the risk of serious heart and vascular events. As populations age and lifestyles change, these diseases are becoming more common, increasing the need for effective treatments. For instance, according to the Centers for Diseases Control and Preventions (CDC), CAD is the most common type of heart disease and a leading cause of death for both men and women in the U.S. In 2022, CAD was responsible for 371,506 deaths in the U.S.

Stents are a key part of minimally invasive procedures that restore blood flow and relieve symptoms. Many patients have both coronary and peripheral issues, which increases demand for stents that work in different areas of the body. Rising awareness, earlier diagnosis, and improved access to advanced interventional procedures in both developed and developing countries has increased utilization of stent globally. These factors are expected to keep demand for stents rising in the years ahead.

Coronary and Peripheral Stents Market Size and Share Analysis

By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Drug-Eluting Stents are dominant due to their ability to slowly release medication, which effectively prevents the re-narrowing of the artery (restenosis). This leads to better long-term patient outcomes compared to bare-metal stents.

By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. Metal stents are dominant because they offer superior mechanical strength, durability, and a low rate of fracture. Materials like cobalt-chromium allow for thinner struts, improving flexibility and biocompatibility.

By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The Coronary Artery Disease segment held the largest share of the market in 2024. Coronary artery disease is the leading application as it is a major cause of death worldwide. The high prevalence of the disease, coupled with the effectiveness of stents as a primary treatment, drives its high demand.

By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Hospitals dominate as end users because stent implantation is a complex surgical procedure performed by specialized interventional cardiologists in a hospital setting. Hospitals are equipped with the necessary infrastructure for these procedures and post-operative care.